Ophthalmology

The CGTLive™ Ophthalmology specialty topic page includes the most recent clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for disorders and diseases of the eye. It also contains video interviews with key opinion leaders in the field of ophthalmology discussing related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for ophthalmic conditions.

Latest News

NGGT Biotechnology’s Gene Therapy NGGT001 Improves Vision in Patients With Bietti’s Crystalline Dystrophy
NGGT Biotechnology’s Gene Therapy NGGT001 Improves Vision in Patients With Bietti’s Crystalline Dystrophy

May 9th 2024

In terms of safety, NGGT001 was deemed well-tolerated.

Rod-Cone Dystrophy Gene Therapy Demonstrates Acceptable Safety, Study to Continue
Rod-Cone Dystrophy Gene Therapy Demonstrates Acceptable Safety, Study to Continue

May 9th 2024

Around the Helix: Cell and Gene Therapy Company Updates – May 8, 2024
Around the Helix: Cell and Gene Therapy Company Updates – May 8, 2024

May 8th 2024

Around the Helix: Cell and Gene Therapy Company Updates – May 1, 2024
Around the Helix: Cell and Gene Therapy Company Updates – May 1, 2024

May 1st 2024

Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024
Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024

April 24th 2024

Latest CME Events & Activities

More News

Around the Helix: Cell and Gene Therapy Company Updates – August 3, 2022

Around the Helix: Cell and Gene Therapy Company Updates – August 3, 2022

Noah Stansfield
August 3rd 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – July 29, 2022

CGTLive’s Weekly Rewind – July 29, 2022

CGTLive Staff
July 29th 2022

Review top news and interview highlights from the week ending July 29, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – July 27, 2022

Around the Helix: Cell and Gene Therapy Company Updates – July 27, 2022

Noah Stansfield
July 27th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Nanoscope Gene Therapy Continues Progress in Stargardt Disease

Nanoscope Gene Therapy Continues Progress in Stargardt Disease

Victoria Johnson
July 26th 2022

Data is expected in the first quarter of 2023 for both Stargardt disease and retinitis pigmentosa.

Gene Therapy Shows Durable Bilateral Improvements in Leber Hereditary Optical Neuropathy

Gene Therapy Shows Durable Bilateral Improvements in Leber Hereditary Optical Neuropathy

Victoria Johnson
July 25th 2022

The long-term RESTORE study included data from 55 participants in previous phase 3 trials.

CGTLive’s Weekly Rewind – July 22, 2022

CGTLive’s Weekly Rewind – July 22, 2022

CGTLive Staff
July 22nd 2022

Review top news and interview highlights from the week ending July 22, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – July 20, 2022

Around the Helix: Cell and Gene Therapy Company Updates – July 20, 2022

Noah Stansfield
July 20th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – July 15, 2022

CGTLive’s Weekly Rewind – July 15, 2022

CGTLive Staff
July 15th 2022

Review top news and interview highlights from the week ending July 15, 2022.

Ixo-Vec Back in Phase 2 Trials, Now for Wet Age-Related Macular Degeneration

Ixo-Vec Back in Phase 2 Trials, Now for Wet Age-Related Macular Degeneration

Victoria Johnson
July 14th 2022

After submitting an amended IND, Adverum’s gene therapy is set to be evaluated in the phase 2 LUNA trial.

Around the Helix: Cell and Gene Therapy Company Updates – July 13, 2022

Around the Helix: Cell and Gene Therapy Company Updates – July 13, 2022

Noah Stansfield
July 13th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

The Growing Popularity of Gene Therapy for Retinal Diseases

The Growing Popularity of Gene Therapy for Retinal Diseases

Ben Shaberman
July 11th 2022

Foundation Fighting Blindness is helping to support the development of gene therapies for retinal diseases.

Around the Helix: Cell and Gene Therapy Company Updates – July 6, 2022

Around the Helix: Cell and Gene Therapy Company Updates – July 6, 2022

Noah Stansfield
July 6th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – July 1, 2022

CGTLive’s Weekly Rewind – July 1, 2022

CGTLive Staff
July 1st 2022

Review top news and interview highlights from the week ending July 1, 2022.

Gene Therapy Improves Outcomes, Yields Sustained Aflibercept Expression in Wet AMD

Gene Therapy Improves Outcomes, Yields Sustained Aflibercept Expression in Wet AMD

Victoria Johnson
June 30th 2022

ADVM-022 was also granted PRIME designation by the EMA on June 24, 2022.

Gene Therapy for X-Linked Retinitis Pigmentosa Shows Safety, Efficacy in Phase 1/2 Study

Gene Therapy for X-Linked Retinitis Pigmentosa Shows Safety, Efficacy in Phase 1/2 Study

Noah Stansfield
June 30th 2022

Improvements were reported in retinal function, visual function, and functional vision at 6 months post-treatment.

Around the Helix: Cell and Gene Therapy Company Updates – June 29, 2022

Around the Helix: Cell and Gene Therapy Company Updates – June 29, 2022

Noah Stansfield
June 29th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – June 24, 2022

CGTLive’s Weekly Rewind – June 24, 2022

CGTLive Staff
June 24th 2022

Review top news and interview highlights from the week ending June 24, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – June 22, 2022

Around the Helix: Cell and Gene Therapy Company Updates – June 22, 2022

Victoria Johnson
June 22nd 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – June 17, 2022

CGTLive’s Weekly Rewind – June 17, 2022

CGTLive Staff
June 17th 2022

Review top news and interview highlights from the week ending June 17, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – June 15, 2022

Around the Helix: Cell and Gene Therapy Company Updates – June 15, 2022

Victoria Johnson
June 15th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – June 10, 2022

CGTLive’s Weekly Rewind – June 10, 2022

CGTLive Staff
June 10th 2022

Review top news and interview highlights from the week ending June 10, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – June 8, 2022

Around the Helix: Cell and Gene Therapy Company Updates – June 8, 2022

Victoria Johnson
June 8th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – June 3, 2022

CGTLive’s Weekly Rewind – June 3, 2022

Victoria Johnson
June 3rd 2022

Review top news and interview highlights from the week ending June 3, 2022.

Around the Helix: Cell and Gene Therapy Company Updates – June 1, 2022

Around the Helix: Cell and Gene Therapy Company Updates – June 1, 2022

Victoria Johnson
June 1st 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – May 27, 2022

CGTLive’s Weekly Rewind – May 27, 2022

CGTLive Staff
May 27th 2022

Review top news and interview highlights from the week ending May 27, 2022.

Developing Safer Viral Vectors for Gene Therapy

Developing Safer Viral Vectors for Gene Therapy

Victoria Johnson
May 26th 2022

The chief executive officer of Ring Therapeutics, Tuyen Ong, MD, discussed the potential of anellovirus vectors for use in gene therapy.

Around the Helix: Cell and Gene Therapy Company Updates – May 25, 2022

Around the Helix: Cell and Gene Therapy Company Updates – May 25, 2022

Victoria Johnson
May 25th 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive’s Weekly Rewind – May 20, 2022

CGTLive’s Weekly Rewind – May 20, 2022

CGTLive Staff
May 20th 2022

Review top news and interview highlights from the week ending May 20, 2022.

Around the Helix at ASGCT: Cell and Gene Therapy Company Updates – May 18, 2022

Around the Helix at ASGCT: Cell and Gene Therapy Company Updates – May 18, 2022

CGTLive Staff
May 18th 2022

Catch up on the latest news and announcements in cell and gene therapies presented at the annual ASGCT meeting.

X-Linked Retinitis Pigmentosa Gene Therapy Improves BCVA

X-Linked Retinitis Pigmentosa Gene Therapy Improves BCVA

Victoria Johnson
May 16th 2022

Interim data from the phase 2 Skyline trial demonstrated a 62.5% response rate.

<1
...
5678910111213
...
17>
© 2024 MJH Life Sciences

All rights reserved.